Serial testing for latent tuberculosis infection in transplant candidates: a retrospective review
- 3 February 2016
- journal article
- review article
- Published by Wiley in Transplant Infectious Disease
- Vol. 18 (1), 14-21
- https://doi.org/10.1111/tid.12489
Abstract
Accurately identifying latent tuberculosis (TB) infection (LTBI) in liver and renal transplant candidates is important because of the risks associated with both treatment of LTBI and reactivation of disease in this population. Many programs advocate yearly screening of patients awaiting organ transplantation. The reproducibility of serial interferon-gamma release assay (IGRA) testing in transplant candidates has not been studied. We conducted a retrospective longitudinal study of patients listed for liver or kidney transplantation between January 1, 2005 and February 1, 2012 at the University of Illinois Medical Center at Chicago. Data collected included demographics, transplant type, IGRA results, treatment received, and mortality. The study population was comprised of 795 adults; 79 (10%) had at least 1 indeterminate result; indeterminate results were less common in men (P = 0.01) and more common in liver transplant candidates (P < 0.001). The reversion frequency was 27% with a rate of 158.1 reversions in 1000 person-years. A higher magnitude of initial TB response values was predictive of consistently positive results (P < 0.001). The conversion frequency was 15% with a rate of 82.6 conversions in 1000 person-years. Among those who converted, the values of the IGRA varied, with 48% having a TB response of 5 IU/mL. A significant number of conversions and reversions occur during serial IGRA testing of transplant candidates. Delineating true-positive converters from false-positives is an issue that warrants further study.Keywords
This publication has 21 references indexed in Scilit:
- Mycobacterium tuberculosis Infections in Solid Organ TransplantationAmerican Journal of Transplantation, 2013
- Repeat IGRA Testing in Canadian Health Workers: Conversions or Unexplained Variability?PLOS ONE, 2013
- QuantiFERON-TB Gold In-Tube test for diagnosis of latent tuberculosis (TB) infection in solid organ transplant candidates: a single-center study in an area endemic for TBTransplant Infectious Disease, 2012
- Within-Subject Interlaboratory Variability of QuantiFERON-TB Gold In-Tube TestsPLOS ONE, 2012
- Comparison of the QuantiFERON‐TB Gold In‐Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantationTransplant Infectious Disease, 2012
- Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic reviewJournal of Occupational Medicine and Toxicology, 2012
- Within-Subject Variability of Mycobacterium tuberculosis-Specific Gamma Interferon Responses in German Health Care WorkersClinical and Vaccine Immunology, 2011
- Latent Tuberculosis Infection in the United StatesThe New England Journal of Medicine, 2011
- Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic reviewThorax, 2011
- Comparison of Quantiferon-TB Gold With Tuberculin Skin Test for Detecting Latent Tuberculosis Infection Prior to Liver TransplantationAmerican Journal of Transplantation, 2007